ClinicalTrials.Veeva

Menu

Optimisation of Cardiac Resynchronisation Therapy by Non-invasive Cardiac Output - The CHOICE2 Study

U

University of Dundee

Status

Completed

Conditions

Heart Failure
Cardiac Resynchronisation Pacemakers

Treatments

Device: Optimisation of VV delay

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

An evaluation of the role of resting and exercise cardiac output measurement, by the inert gas rebreathing method, in optimisation of patients with cardiac resynchronisation pacemakers.

Enrollment

31 patients

Sex

All

Ages

18 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Cardiac Resynchronization Device in situ for Heart Failure

Exclusion criteria

  • Unable to cope with mouthpiece
  • Estimated life expectancy < 6 months

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

Quadruple Blind

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems